# KVP Capital Advisors, LP: Form 13F holdings

An institutional investment manager in SAN FRANCISCO, CA. SEC CIK 1858198.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $136.2m
- Positions: 35 (35 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1858198/000110465926095988/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [PRAXIS PRECISION MEDICINES I (PRAX)](/companies/prax.md) | COM NEW | $14.4m | 10.5% | 42,900 |  | Unchanged |
| [WHITEHAWK THERAPEUTICS INC (WHWK)](/companies/whwk.md) | COM | $9.9m | 7.3% | 2,165,997 |  | Unchanged |
| [ERASCA INC (ERAS)](/companies/eras.md) | COM | $8.3m | 6.1% | 455,000 |  | Added +115,000 |
| [TREVI THERAPEUTICS INC (TRVI)](/companies/trvi.md) | COM | $7.7m | 5.7% | 414,000 |  | Unchanged |
| [SUTRO BIOPHARMA INC (STRO)](/companies/stro.md) | COM SHS | $7.5m | 5.5% | 226,575 |  | Unchanged |
| [TANGO THERAPEUTICS INC (TNGX)](/companies/tngx.md) | COM | $7.2m | 5.3% | 230,264 |  | Unchanged |
| [MBX BIOSCIENCES INC (MBX)](/companies/mbx.md) | COM | $6.7m | 4.9% | 121,524 |  | Unchanged |
| [PROTAGONIST THERAPEUTICS INC (PTGX)](/companies/ptgx.md) | COM | $6.5m | 4.8% | 53,000 |  | Unchanged |
| [EDGEWISE THERAPEUTICS INC (EWTX)](/companies/ewtx.md) | COM | $5.4m | 4.0% | 133,000 |  | Unchanged |
| [TANDEM DIABETES CARE INC (TNDM)](/companies/tndm.md) | COM NEW | $4.5m | 3.3% | 301,000 |  | New +301,000 |
| [DISC MEDICINE INC (IRON)](/companies/iron.md) | COM | $4.3m | 3.1% | 58,250 |  | Unchanged |
| [SAVARA INC (SVRA)](/companies/svra.md) | COM | $3.7m | 2.7% | 605,280 |  | Unchanged |
| [ARRIVENT BIOPHARMA INC (AVBP)](/companies/avbp.md) | COM | $3.5m | 2.6% | 102,000 |  | New +102,000 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $3.0m | 2.2% | 28,497 |  | Unchanged |
| [ACHIEVE LIFE SCIENCES INC (ACHV)](/companies/achv.md) | COM | $3.0m | 2.2% | 462,355 |  | Unchanged |
| [IDEAYA BIOSCIENCES INC (IDYA)](/companies/idya.md) | COM | $3.0m | 2.2% | 79,700 |  | Unchanged |
| [OCULAR THERAPEUTIX INC (OCUL)](/companies/ocul.md) | COM | $2.9m | 2.2% | 300,000 |  | Unchanged |
| [AXSOME THERAPEUTICS INC. (AXSM)](/companies/axsm.md) | COM | $2.9m | 2.2% | 12,000 |  | Reduced −24,200 |
| [DESIGN THERAPEUTICS INC (DSGN)](/companies/dsgn.md) | COM | $2.7m | 2.0% | 185,000 |  | New +185,000 |
| [UNITED THERAPEUTICS CORP DEL (UTHR)](/companies/uthr.md) | COM | $2.6m | 1.9% | 4,750 |  | Unchanged |
| [SCHOLAR ROCK HLDG CORP (SRRK)](/companies/srrk.md) | COM | $2.5m | 1.8% | 45,000 |  | Unchanged |
| [IMMIX BIOPHARMA INC (IMMX)](/companies/immx.md) | COM | $2.4m | 1.7% | 230,423 |  | Unchanged |
| [VIRIDIAN THERAPEUTICS INC (VRDN)](/companies/vrdn.md) | COM | $2.3m | 1.7% | 125,000 |  | Unchanged |
| [MINERALYS THERAPEUTICS INC (MLYS)](/companies/mlys.md) | COM | $2.3m | 1.7% | 84,168 |  | New +84,168 |
| [BRIGHT MINDS BIOSCIENCES INC (DRUG)](/companies/drug.md) | COM NEW | $2.2m | 1.6% | 31,813 |  | Unchanged |
| [TRAVERE THERAPEUTICS INC (TVTX)](/companies/tvtx.md) | COM | $2.2m | 1.6% | 39,000 |  | Reduced −52,000 |
| ZURA BIO LTD | CLASS A ORD SHS | $2.2m | 1.6% | 373,128 |  | Unchanged |
| [ARTIVA BIOTHERAPEUTICS INC (ARTV)](/companies/artv.md) | COM | $1.9m | 1.4% | 200,000 |  | New +200,000 |
| [NEKTAR THERAPEUTICS (NKTR)](/companies/nktr.md) | COM NEW | $1.9m | 1.4% | 26,900 |  | Unchanged |
| [COMPASS THERAPEUTICS INC (CMPX)](/companies/cmpx.md) | COM | $1.7m | 1.2% | 771,000 |  | Added +271,000 |
| [CABALETTA BIO INC (CABA)](/companies/caba.md) | COM | $1.6m | 1.2% | 505,431 |  | Unchanged |
| [VERA THERAPEUTICS INC (VERA)](/companies/vera.md) | CL A | $1.4m | 1.0% | 32,700 |  | Unchanged |
| [EVOLUS INC (EOLS)](/companies/eols.md) | COM | $1.0m | 0.8% | 150,000 |  | New +150,000 |
| [CELCUITY INC (CELC)](/companies/celc.md) | COM | $418.5k | 0.3% | 4,000 |  | Unchanged |
| VYNE THERAPEUTICS INC | COM | $325.7k | 0.2% | 500,551 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $0 | 0.0% | 0 |  | Sold out −40,200 |
| SOLENO THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −59,700 |
| TERNS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −440,000 |

Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-095988. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.